You may also like
Coronary Artery Bypass Grafting after Aprotinin: Are We Doing Better?
Accordingly, the usage of aprotinin should be reconsidered for treatment among cohorts of low-risk cardiac patients.
1 min read
Hemoadsorption Eliminates Remdesivir from the Circulation: Implications for the Treatment of COVID-19
Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID-19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several therapeutic drugs. In this study, we evaluated whether remdesivir and its main active metabolite GS-441524 would be adsorbed by CytoSorb®.
1 min read